FDA Drug Recalls

Recalls / Class II

Class IID-268-2013

Product

Amoxicillin Capsules USP 500 mg, Manufactured in Austria by Sandoz GmbH for Sandoz Inc., Princeton, NJ 08540, Rx only. Manufactured in 500 ct (NDC 0781-2613-05) and 30 ct (NDC 0781-2613-31) bottles.

Brand name
Amoxicillin
Generic name
Amoxicillin
Active ingredient
Amoxicillin
Route
Oral
NDCs
0781-2020, 0781-2613, 0781-5060, 0781-5061, 0781-6039, 0781-6156, 0781-6041, 0781-6157
FDA application
ANDA064076
Affected lot / code info
CK2003, CK2004 exp. 04/15, CR4110, CR4111, CS2983, CS2986, CS2988, CS2989, CS2990, CS2991, CS2992, CS2993, CS2994 exp. 07/15, CK3616, CK3617 exp. 04/15

Why it was recalled

Presence of Foreign Substance, Sandoz is recalling certain lots of Amoxicillin Capsules, USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.

Recalling firm

Firm
Sandoz Incorporated
Manufacturer
Sandoz Inc
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
2555 W Midway Blvd, Broomfield, Colorado 80020-1632

Distribution

Quantity
8286 x 30 ct, 37108 x 500 ct. bottles
Distribution pattern
Nationwide

Timeline

Recall initiated
2013-04-18
FDA classified
2013-04-23
Posted by FDA
2013-05-01
Terminated
2014-02-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-268-2013. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.